Sources | Names Used |
---|---|
CTRPv2 | salermide:PLX-4032 (12:1 mol/mol) |
PharmacoGx | salermide:PLX-4032 (12:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KLF9 | CTRPv2 | pan-cancer | AAC | 0.29 | 2e-11 |
mRNA | LAMA4 | CTRPv2 | pan-cancer | AAC | 0.28 | 2e-11 |
mRNA | CD200 | CTRPv2 | pan-cancer | AAC | 0.27 | 2e-11 |
mRNA | FNTB | CTRPv2 | pan-cancer | AAC | 0.3 | 2e-11 |
mRNA | GPNMB | CTRPv2 | pan-cancer | AAC | 0.31 | 2e-11 |
mRNA | SRPX | CTRPv2 | pan-cancer | AAC | 0.31 | 3e-11 |
mRNA | BBS5 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-11 |
mRNA | ACP5 | CTRPv2 | pan-cancer | AAC | 0.28 | 5e-11 |
mRNA | TSNAX | CTRPv2 | pan-cancer | AAC | 0.26 | 5e-11 |
mRNA | GPR155 | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |